PepMSND: Integrating Multi-level Feature Engineering and Comprehensive Databases to Enhance in vivo/in vitro Peptide Blood Stability Prediction

preprint OA: closed
📄 Open PDF View at publisher
AI-generated summary by claude@2026-07, 2026-07-15

PepMSND integrates multi-level feature engineering with KAN, Transformer, GAT, and SE(3)-Transformer models to accurately predict peptide blood stability, achieving 0.8672 ACC and 0.9118 AUC.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Deep learning technology has revolutionized the field of peptides, but key questions such as how to predict the blood stability of peptides remain. While such a task can be accomplished by experiments, it requires much time and cost. Here, to address this challenge, we collect extensive experimental data on peptide stability in blood from public databases and literature and construct a database of peptide blood stability that includes 635 samples. Based on this database, we develop a novel model called PepMSND, integrating KAN, Transformer, GAT and SE(3)-Transformer to make multi-level feature engineering to make peptide stability prediction. Our model can achieve the ACC of 0.8672 and the AUC of 0.9118 on average and outperforms the baseline models. This work can facilitate the development of novel peptides with strong stability, which is crucial for their therapeutic use in clinical applications.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00